Taiwan FDA registration d4e8044232d6bc022d521bd6fa1f6e08

GE blood glucose monitoring systems

TW: GE 血糖監測系統
Taiwan flagTaiwan·Risk Class 2·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered May 18, 2022 – May 18, 2027Active
Registration details
Analysis ID
d4e8044232d6bc022d521bd6fa1f6e08
Company information
Manufacturer Country
Taiwan, Province of China
Product details
Intended Use
This product is designed by the In Vitro Institute (self-test and professional use) to measure fresh whole blood glucose obtained through the microvessels of the fingertip, palm or arm.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1345 Glucose Test System
Import Information
QMS/QSD;; 國產
Dates and status
Registration Date
May 18, 2022
Expiry Date
May 18, 2027
Companies making similar products

Top companies providing products similar to "GE blood glucose monitoring systems"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for GE blood glucose monitoring systems in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d4e8044232d6bc022d521bd6fa1f6e08 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Daqing Factory of Huaguang Biotechnology Co., Ltd, and 3 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors3 Recent Registrations